Methylimidazole Case Study

1610 Words4 Pages

1-methylimidazole (DY 070, Huntsman, Germany) was used as curing agent. Three different types of thermoplastic epoxy resins (NPES-903, Nan Ya epoxy resin, Taiwan; Epotec YD 012, Aditya Birla Chemicals Ltd, Thailand and Epiran-01, Khozestan petrochemical, Iran) were used as the capsulation agent. Epikote 828 was purchased from Momentive Co (USA), used as the host polymeric matrix. Characteristic properties of the used epoxy resins are tabulated in Table 1. Figure 1 shows the chemical structure of these epoxy resins that are diglycidyl ether of bisphenol A. In these epoxy resins the liquid epoxy has an n value 1 or blow and the solid epoxy has n value above 1. Sodium dodecyl sulfate (SDS) emulsifier and acetone solvent were purchased from Aldrich.
Microencapsulation procedure
An aqueous phase of the emulsifier was prepared containing 200 mg dissolved SDS in 200 mL distillated water. 1-methylimidazole (1-MI) and a solid epoxy resin, at three SER to 1-MI rations (30/70, 50/50 and 70/30) were dissolved in acetone (15 mL) and gently added to the continuous aqueous phase (1 wt% SDS in distilled water) under mechanical stirring (RZR 2102, Heidolph) at 500, 1000 and 1500 rpm to achieve an O/W …show more content…

For epoxy resin systems containing 20 phr microcapsules prepared at mixing speed of 500 rpm in different SER/1-MI ratios, gel times values are almost constant, and therefore the 1-MI content of these microcapsules nearly were not changed. Besides, by increasing the initial quantity of NPES-903 for preparing microcapsules at mixing speed of 1500 rpm, gel time value of epoxy resin systems containing 20 phr of these microcapsules increases (Figure 8) or the 1-MI content of these microcapsules decreases. Because of in constant microcapsule concentration, different in gel times relate to 1-MI contents (Figure 3). These confirm the TGA

More about Methylimidazole Case Study

Open Document